I migliori medici per il trattamento di Tumori neuroendocrini del pancreas all'estero — Pagina 4

Zhang Jinshan, male, China’s First M.D. in the Radiation Medicine, CCI (Chinese College of Interventionalists) Master Interventionalist, Director of the Department of Former Radiological Diagnosis at Chinese PLA General Hospital(No.3 in China) Ph.D. of Medicine, Nagasaki University, Japan.

1980–1985: Completed doctoral studies at Nagasaki University, Japan

1968–present: Department of Radiology, Chinese PLA General Hospital

1988: Third Prize of the Military Science and Technology Progress Award

1989–present: Member of Radiological Society of North America(RSNA)

1990–2009: Standing Committee Member of the Radiology and Therapeutic Radiology Committee of the PLA

1991: Second Prize of the Military Science and Technology Progress Award

1992–2008: Group Leader of the Group of Intervention of Chinese Journal of Radiology

1992–2015: Standing Editorial Board Member and Editorial Board Member of Journal of Interventional Radiology

1993: Granted the Lifetime Special Government Allowance of the State Council

1993–2012: Deputy Chief Editor of Chinese Journal of Medical Image Technology

1994: Third Prize of the Military Science and Technology Progress Award

1997: Second Prize of the Military Science and Technology Progress Award

1997–2009: Standing Member of Chinese Society of Radiology

1999: Third Prize of the Military Science and Technology Progress Award

1999–2010: Deputy Director Member of Chinese Society of Interventional Oncology

2002: Second Prize of the Military Science and Technology Progress Award

2005: Third Prize of the Military Science and Technology Progress Award

Member of Radiological Society of North America(RSNA)

Standing Member of Chinese Society of Radiology

Group Leader of the Group of Intervention of Chinese Journal of Radiology

Deputy Director Member of Chinese Society of Interventional Oncology

Director Member of Beijing Medical Association Society of Interventional Radiology

Deputy Chief Editor of Chinese Journal of Medical Image Technology

Standing Member of Professional Committee of Radiological Medicine of the Chinese People’s Liberation Army

Standing Editorial Board Member and Editorial Board Member of Journal of Interventional Radiology

Awarded the Special Government Allowance of the State Council

Awarded three Second Prizes and four Third Prizes for Military Science and Technology Progress.

Awarded the honorary title of “Chinese College of Interventionalists(CCI) Master Interventionalist”

Led multiple national and provincial/ministerial scientific research projects, including two projects funded by the National Natural Science Foundation of China and two projects funded by the Department of Science and Technology of Sichuan Province.

In the pioneering development of interventional medicine in China, Zhang Jinshan has been an indispensable founder and leading figure. As China’s first overseas-trained doctoral graduate in radiological medicine, he returned to China in the 1980s after completing his studies abroad and introduced cutting-edge international interventional technologies to the country. Over more than four decades of dedicated practice and research, he has helped propel Chinese interventional medicine from its infancy to a position at the forefront of the global field through his exceptional clinical expertise and profound academic accomplishments.

Professor Zhang Jinshan has long been dedicated to the field of medical imaging and has developed distinctive expertise in selective and superselective interventional diagnosis and treatment for solid tumors such as liver cancer, demonstrating exceptional technical proficiency and profound academic accomplishment. Beginning in the 1990s, he led his team in pioneering the clinical application and research of TIPSS and B-ORTO in China, filling major gaps in the domestic field and opening new paths for the interventional management of gastrointestinal bleeding caused by portal hypertension secondary to liver cirrhosis. In addition, he has made groundbreaking contributions to the interventional diagnosis and treatment of peripheral vascular diseases, as well as to preoperative embolization for spinal tumors.

In the field of liver cancer treatment, Professor Zhang Jinshan not only led the development of standardized treatment protocols for liver cancer but also pioneered Transcatheter Arterial Chemoembolization with temporary Hepatic Vein Thrombosis (TACE-THVO) for primary liver cancer, bringing the efficacy of interventional therapy to a new level. In recognition of his outstanding clinical and scientific contributions, he was awarded the honorary title of “Chinese Master of Interventional Radiology” at the 2019 annual conference of the Chinese College of Interventionalists.

Professor Zhang Jinshan is not only a master clinician but also a driving force in the development of the discipline and a dedicated mentor in talent cultivation. He led his team in establishing one of China’s premier interventional therapy centers. As a doctoral supervisor, he has trained a large number of outstanding specialists and future leaders in interventional medicine, with many of his students and protégés now serving across the country. Academically, he has led multiple key national and military research projects, published more than 300 academic papers, and served as chief editor of three monographs, making remarkable contributions to the establishment of China’s academic framework for interventional medicine and the nationwide dissemination of its technologies.

From the laboratory to the operating room, and from academic podiums to grassroots hospitals, Professor Zhang Jinshan has consistently upheld the principles of “pioneering, innovation, pragmatism, and compassion". He has devoted his life to fulfilling the mission of a physician—relieving patients’ suffering through minimally invasive techniques and advancing the discipline through academic excellence—thereby establishing himself as a truly towering figure and one of the foremost authorities in the field of interventional medicine in China.

Professor Zhang Jinshan’s Academic Achievements

Professor Zhang Jinshan has achieved prolific academic accomplishments, having published over 300 academic papers covering areas such as interventional therapy for liver cancer, minimally invasive treatment of portal hypertension, interventional treatment of vascular diseases, and tumor ablation.

Selected Publications by Professor Zhang Jinshan

1. Zhang Jinshan, Wang Maoqiang. Experiments and Clinical Studies of transjugular intrahepatic portosystemic stent shunt (TIPSS). Chinese Journal of Radiology, 1993，27（6）：361-365.

Professor Zhang Jinshan is the first author. This is one of the early research papers in China that systematically elaborates on the TIPSS technique. Through animal experiments and clinical case analysis, it confirmed that TIPSS is a safe and effective minimally invasive method for treating portal hypertension and its complications, laying an important foundation for the promotion and application of this technique in China.

2.Zhang Jinshan, Li Huai. Clinical study on transcatheter arterial embolization with temporary hepatic vein occlusion for the treatment of primary liver cancer.Chinese Journal of Radiology, 1996，30（8）：521-524.

Professor Zhang Jinshan is the first author. He innovatively proposed the technique of "transcatheter arterial embolization with temporary hepatic vein occlusion." Clinical results demonstrated that this method can significantly increase the drug concentration within liver cancer lesions, reduce damage to normal liver tissue, and effectively improve the therapeutic outcomes for intermediate and advanced liver cancer, providing a novel strategy for the interventional treatment of liver cancer.

3. Zhang Jinshan, Wang Maoqiang, Li Huai. Interventional treatment of Budd-Chiari syndrome. Chinese Journal of Medical Imaging Technology, 1998，14（3）：189-191.

Professor Zhang Jinshan is the first author. This paper systematically summarizes the early experience in interventional treatment of Budd-Chiari syndrome in China, elaborating in detail on the key operational points and therapeutic efficacy of techniques such as percutaneous transluminal angioplasty and stent placement. It confirms that interventional therapy is the preferred minimally invasive method for Budd-Chiari syndrome, promoting the standardized development of treatment for this disease.

4.Zhang Jinshan, Li Huai, Wang Maoqiang. Clinical value of superselective hepatic arterial chemoembolization in the treatment of hypovascular liver cancer. Chinese Journal of Radiology, 2000，34（5）：335-337.

Professor Zhang Jinshan is the first author. Addressing the challenges in interventional treatment of hypovascular liver cancer, this paper explores the clinical efficacy of superselective hepatic arterial chemoembolization. The results indicate that this technique can precisely target the lesions and improve the treatment response rate, providing an important clinical basis for the interventional treatment of hypovascular liver cancer.

5. Zhang Jinshan, Li Huai, Wang Maoqiang. Interventional treatment of peripheral vascular stenosis and occlusion.Chinese Journal of Radiology, 2002，36（7）：612-614.

Professor Zhang Jinshan is the first author. This paper summarizes the interventional treatment experience of over 400 patients with peripheral vascular stenosis and occlusion, analyzing the indications and efficacy of techniques such as balloon angioplasty and stent placement. It confirms that interventional therapy is a safe and effective approach for peripheral vascular diseases, providing practical support for its clinical promotion.

6.Zhang Jinshan, Li Huai, Wang Maoqiang. Clinical application of CT-guided percutaneous puncture ablation in the treatment of abdominal tumors. Chinese Journal of Medical Imaging Technology, 2004，20（9）：1395-1397.

Professor Zhang Jinshan is the first author. This paper explores the application value of CT-guided percutaneous puncture techniques such as radiofrequency ablation and chemical ablation in the treatment of abdominal tumors. The clinical results show that this method is minimally invasive with reliable efficacy, offering a minimally invasive treatment option for patients with inoperable abdominal tumors.

7.Zhang Jinshan, Wang Maoqiang, Li Huai. Advances in the application of interventional therapy for benign prostatic hyperplasia. Chinese Journal of Radiology, 2006，40（8）：876-878.

Professor Zhang Jinshan is the corresponding author. This paper systematically reviews the cutting-edge advances in interventional therapy for benign prostatic hyperplasia, including the principles, procedures, and efficacy of techniques such as prostatic artery embolization and stent placement, providing new insights for the minimally invasive treatment of benign prostatic hyperplasia.

8.Zhang Jinshan, Li Huai, Wang Maoqiang. Discussion on the standardization of interventional therapy for liver cancer. Chinese Journal of Practical Surgery, 2008，28（10）：856-858.

Professor Zhang Jinshan is the corresponding author. Drawing on years of clinical experience and research findings, he led the discussion on standardized protocols for interventional therapy of liver cancer, covering key aspects such as preoperative assessment, treatment modality selection, and postoperative management, providing important references for the formulation of clinical guidelines for interventional therapy of liver cancer in China.

Professor Zhang Jinshan co-authored monographs

1. Interventional Radiology (People's Military Medical Press, 1995): The first monograph in China to systematically discuss the theories and techniques of interventional radiology. It comprehensively elaborates on the interventional diagnosis and treatment system for tumors, vascular diseases, and non-vascular diseases, becoming a classic essential textbook for interventional physicians in China.

2.Interventional Therapy for Liver Cancer (People's Health Press, 2001): Focusing on minimally invasive interventions for liver cancer, this book systematically summarizes techniques such as TACE, ablation, and vascular intervention, refines operational standards and the prevention and management of complications, and promotes the standardization of interventional therapy for liver cancer.

3.Interventional Treatment of Portal Hypertension (Science Press, 2005): This book systematically elaborates on minimally invasive techniques for portal hypertension, such as TIPSS and B-ORTO, covering experimental research, clinical procedures, long-term follow-up, and efficacy evaluation, filling the gap in monographs on interventional treatment of portal hypertension in China.

Professor Zhang Jinshan’s Research project

1.The National "Eighth Five-Year Plan" Scientific and Technological Key Project—Clinical and Basic Research on Comprehensive Interventional Therapy for Liver Cancer (Project Leader): This project systematically explored multimodal interventional strategies for liver cancer, established the core regimen of superselective TACE combined with local ablation, and significantly improved the therapeutic outcomes for intermediate and advanced liver cancer.

2.The Military "Ninth Five-Year Plan" Key Medical Scientific Research Project—Standardized Research on TIPSS for the Treatment of Portal Hypertension (Project Leader): This project formulated China's first operational standards and postoperative management guidelines for TIPSS, reduced the incidence of complications, and promoted the popularization of this technique throughout the military and across the country.

3.National Natural Science Foundation of China Project — Research on the Mechanism of Targeted Therapy for Liver Cancer Using Hepatic Vein Occlusion Combined with Chemoembolization (Project Leader): This project revealed the synergistic enhancement mechanisms of the innovative technique at the levels of hemodynamics, drug metabolism, and the tumor microenvironment, providing theoretical support for precision interventional therapy of liver cancer.

4.Military Clinical High-Tech Major Project-Establishment and Clinical Application of the Interventional Treatment Technology System for Complex Vascular Diseases (Project Leader): This project overcame interventional challenges in complex lesions such as Budd-Chiari syndrome, peripheral vascular occlusion, and vascular malformations, forming a complete technical system that has been promoted and applied widely.

Il Dr. Volkan Kinas è specializzato in chirurgia pancreatica, concentrandosi sui tumori neuroendocrini presso gli ospedali Büyük Anadolu.

• Specializzato sia in chirurgia pancreatica che oncologica
• Gestisce casi complessi che coinvolgono il cancro delle vie biliari e dello stomaco
• Esperto in chirurgia metabolica bariatrica
• Lavora all'interno di un team multidisciplinare per un'assistenza completa

Il Dr. Beni Boursi è un oncologo di spicco presso lo Sheba Medical Center. Ha fondato il gruppo di lavoro sul microbioma ECOG-ACRIN. È specializzato nel trattamento dei tumori gastrointestinali utilizzando l'innovativa modulazione microbica. Il Dr. Boursi è certificato in medicina interna e oncologia medica. Ha conseguito la laurea in medicina con il massimo dei voti presso l'Università di Tel Aviv.

• Ha completato fellowship in oncologia presso l'Università della Pennsylvania.
• Si è formato in oncologia medica presso l'MD Anderson e la Mayo Clinic.
• Ha sviluppato modelli predittivi per la diagnosi precoce del cancro al colon-retto e al pancreas.
• Ha pubblicato ricerche sul microbioma in oncologia sulla prestigiosa rivista Science.

Il Dr. Yaacov Lawrence è il Direttore di Radioterapia Oncologica presso lo Sheba Medical Center. È specializzato in radioterapia di precisione e neuro-oncologia. Il Dr. Lawrence è stato un pioniere della radiochirurgia del plesso celiaco per la gestione del dolore nel cancro al pancreas. Detiene la designazione FASTRO, una delle più alte onorificenze nella sua specialità.

• Dirige il programma per i tumori gastrointestinali presso lo Sheba Medical Center.
• Esegue radiochirurgia stereotassica per tumori cerebrali e tumori del sistema nervoso.
• Autore di oltre 280 pubblicazioni scientifiche su protocolli di radioterapia personalizzati.
• Ha completato il fellowship in radioterapia oncologica presso la Thomas Jefferson University.

La Prof.ssa Elke Jaeger è una delle principali oncologhe tedesche, riconosciuta da Focus per 41 anni. Dirige il reparto di Oncologia ed Ematologia presso la Clinica Nordwest.

• 41 anni di esperienza in oncologia
• Ha eseguito oltre 1.100 procedure oncologiche
• Membro della commissione di esperti dell'EORTC
• Pubblicazioni citate in oltre 7.000 fonti scientifiche
• Specializzata in sarcomi e tumori neuroendocrini

Il Dr. Tarkan è specializzato in interventi chirurgici complessi per il cancro allo stomaco e i tumori neuroendocrini pancreatici presso la Klinik Mavi.

• Membro dell'Associazione Turca di Chirurgia Bariatrica
• Membro della Federazione Internazionale di Chirurgia dell'Obesità e dei Disturbi Metabolici
• Laureato presso la Facoltà di Medicina dell'Università di Dicle

Il Dr. Atakan Topcu è un oncologo medico presso l'ospedale Medipol Acibadem District di Istanbul. È specializzato nel trattamento dei tumori solidi, inclusi il cancro al polmone, al seno e al colon-retto. Il Dr. Topcu è professore associato con oltre 50 pubblicazioni scientifiche sottoposte a revisione paritaria. Fa parte del comitato editoriale della rivista medica BMC Cancer.

• Esperienza in immunoterapia, terapie mirate e assistenza oncologica geriatrica.
• Tratta la malnutrizione correlata al cancro, la cachessia e la sarcopenia.
• Membro attivo della Società Europea di Oncologia Medica (ESMO).
• Lavora in un ospedale accreditato JCI specializzato in trattamenti oncologici avanzati.

La professoressa Gul Alco è specializzata in oncologia radioterapica con oltre due decenni di esperienza, attualmente presso l'Università Medipol di Istanbul.

• Professoressa di Oncologia Radioterapica dal 2021
• Specializzazione completata presso l'Università Kadir Has
• Vasta esperienza nel trattamento dei tumori neuroendocrini del pancreas
• Competenza in tecniche avanzate di radioterapia

Oltre 500 procedure mininvasive di successo – Il Dr. Braun è specializzato in tumori neuroendocrini del pancreas e chirurgia gastrointestinale presso il Maria Cecilia Hospital.

• _doctor_7234_anni_ di esperienza in chirurgia gastrointestinale
• Formato alla Johns Hopkins University in chirurgia epatobiliare e pancreatica
• Membro della Società Italiana di Chirurgia dell'Obesità (SICOB)
• Si concentra su casi complessi e piani di trattamento personalizzati

Specializzato in oncologia radioterapica per tumori neuroendocrini del pancreas presso l'Emsey Hospital.

• Formato presso la Facoltà di Medicina dell'Università di Marmara
• Ha completato la specializzazione in oncologia radioterapica
• Si concentra sulla pianificazione precisa del trattamento

Il Prof. Associato Nail Paksoy è specializzato in tumori neuroendocrini pancreatici, supportato dalla certificazione ESMO e da un'ampia ricerca in oncologia.

• Fellowship in Oncologia Medica presso l'Istituto di Oncologia dell'Università di Istanbul
• Ricerca pubblicata sulle strategie di trattamento per i tumori neuroendocrini
• Partecipazione a studi clinici incentrati su terapie oncologiche avanzate
• Ruolo accademico presso l'Università Medipol di Istanbul

La Dott.ssa Shruti Kate è specializzata in tumori neuroendocrini pancreatici, formata presso il Tata Memorial Hospital, uno dei principali centri oncologici dell'India.

• Esperta nella procedura di Whipple per i tumori pancreatici
• Membro di ASCO, ESMO e altre importanti società oncologiche
• Ha presentato ricerche sul cancro al polmone alla Conferenza Mondiale sul Cancro al Polmone
• Si concentra sull'immunoterapia e sulla terapia metronomica per i tumori in stadio avanzato

Il Dr. Shaunak è specializzato in terapie mirate per i tumori neuroendocrini del pancreas, con ricerche presentate all'esclusivo Simposio sui tumori gastrointestinali.

• Ha completato il DNB in Oncologia Medica presso l'Indraprastha Apollo Hospital
• Ha presentato ricerche sul cancro allo stomaco al simposio ASCO
• Si concentra sulle basi molecolari del cancro
• Residenza senior in Oncologia Medica presso l'Ospedale Oncologico Jawaharlal Nehru

Il Dr. Chaitainya Borde ha eseguito oltre 30.000 scansioni PET e trattato più di 1.000 pazienti affetti da cancro alla tiroide presso l'HCG Manavata Cancer Centre.

• _doctor_2774_anni_ di esperienza in medicina nucleare
• Specializzato in radioiodio e terapie con Lu-177 RN
• Esperto in tutti i tipi di scansioni nucleari e diagnostica per immagini PET-CT
• Ricercatore con pubblicazioni su riviste mediche